Background Eriocalyxin B (EriB), a diterpenoid isolated from the plant Isodon eriocalyx, has
been shown to possess anti-tumor properties. However, few systematic studies of the …

Natural products, a rich source of bioactive chemical compounds, have served humans as a
safer drug of choice since times. Eriocalyxin B, an ent-Kaurene diterpenoid, has been …

Pancreatic cancer is difficult to detect early and responds poorly to chemotherapy. A
breakthrough in the development of new therapeutic agents is urgently needed. Eriocalyxin …

Eriocalyxin B (EriB) has been shown to possess promising anti-cancer potential against
various cancer cells. However, its effect against bladder cancer cells remained unexplored …

Eriocalyxin B (EriB), a natural ent-kaurane diterpenoid presented in the plant Isodon
eriocalyx var. laxiflora, has been reported to diminish angiogenesis-dependent breast tumor …

OBJECTIVE: Eriocalyxin B (EriB) is a natural diterpenoid purified from Isodon eriocalyx var.
laxiflora and possesses strong antileukemic activity. In this study, we further investigated its …

Eriocalyxin B (EriB), a potent ent-kaurene extracted from Isodon eriocalyx, has turned up as
novel anti-cancer agent during recent years against a range of cancer types. TNBC (Triple …

Background Pancreatic cancer, associated with poor prognosis and low survival rate, has
been the fourth leading cause of cancer-related death in the US. Although gemcitabine …

Colorectal cancer is one of the most commonly diagnosed cancers in the world. Currently,
drug resistance of cancer cell to chemotherapy is a major cause for cancer recurrence and …

Eriocalyxin B, a natural ent-kaurene diterpene compound, has been shown to prevent
carcinogenesis and tumor development. However, little is known regarding the mechanism …